Distinct Endosomal Trafficking Requirements for Presentation of Autoantigens and Exogenous Lipids by Human CD1d Molecules1
暂无分享,去创建一个
G. Besra | J. Gumperz | Xiaohuan Wang | P. Illarionov | Xiuxu Chen | F. Reddington | Jason M. Keaton
[1] Chi‐Huey Wong,et al. Conserved and Heterogeneous Lipid Antigen Specificities of CD1d-Restricted NKT Cell Receptors1 , 2006, The Journal of Immunology.
[2] J. Gumperz. The Ins and Outs of CD1 Molecules: Bringing Lipids Under Immunological Surveillance , 2006, Traffic.
[3] K. Sandhoff,et al. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. , 2005, Annual review of cell and developmental biology.
[4] A. Fersht,et al. The crystal structure of human CD1d with and without α-galactosylceramide , 2005, Nature Immunology.
[5] I. Wilson,et al. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor , 2005, Nature Immunology.
[6] L. Kaer,et al. Innate Immunity: NKT Cells in the Spotlight , 2005, Current Biology.
[7] D. Ganem,et al. Regulation of CD1d expression and function by a herpesvirus infection. , 2005, The Journal of clinical investigation.
[8] Archana Khurana,et al. The Mouse CD1d Cytoplasmic Tail Mediates CD1d Trafficking and Antigen Presentation by Adaptor Protein 3-Dependent and -Independent Mechanisms1 , 2005, The Journal of Immunology.
[9] G. Besra,et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Proia,et al. Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.
[11] Michael B Brenner,et al. CD1: antigen presentation and T cell function. , 2004, Annual review of immunology.
[12] M. Brenner,et al. New insights into pathways for CD1-mediated antigen presentation. , 2004, Current opinion in immunology.
[13] P. Savage,et al. Editing of CD1d-Bound Lipid Antigens by Endosomal Lipid Transfer Proteins , 2004, Science.
[14] P. Cresswell,et al. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells , 2004, Nature Immunology.
[15] J. Bonifacino,et al. Signals for sorting of transmembrane proteins to endosomes and lysosomes. , 2003, Annual review of biochemistry.
[16] L. Bry,et al. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection , 2003, Nature Immunology.
[17] G. Besra,et al. Lysosomal Localization of Murine CD1d Mediated by AP-3 Is Necessary for NK T Cell Development 1 , 2003, The Journal of Immunology.
[18] J. Yewdell,et al. Recycling CD1d1 Molecules Present Endogenous Antigens Processed in an Endocytic Compartment to NKT Cells1 , 2002, The Journal of Immunology.
[19] J. Bonifacino,et al. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. , 2002, Immunity.
[20] P. Cresswell,et al. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules , 2002, The EMBO journal.
[21] R. Mehr,et al. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. , 2001, Immunity.
[22] Ira Mellman,et al. Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.
[23] A. Kulkarni,et al. Glycolipid antigen processing for presentation by CD1d molecules. , 2001, Science.
[24] Taniguchi,et al. Differences in the Ligand Specificity between CD1d‐Restricted T Cells with Limited and Diverse T‐Cell Receptor Repertoire , 2000, Scandinavian journal of immunology.
[25] P. Peters,et al. Pathways for Lipid Antigen Presentation by CD1 Molecules: Nowhere for Intracellular Pathogens to Hide , 2000, Traffic.
[26] F. Maxfield,et al. Role of Membrane Organization and Membrane Domains in Endocytic Lipid Trafficking , 2000, Traffic.
[27] S. Porcelli,et al. Murine CD1d-restricted T cell recognition of cellular lipids. , 2000, Immunity.
[28] E. V. van Donselaar,et al. Separate pathways for antigen presentation by CD1 molecules. , 1999, Immunity.
[29] Sushmita Mukherjee,et al. Endocytic Sorting of Lipid Analogues Differing Solely in the Chemistry of Their Hydrophobic Tails , 1999, The Journal of cell biology.
[30] A. Dautry‐Varsat,et al. Distinct Subsets of CD1d-restricted T Cells Recognize Self-antigens Loaded in Different Cellular Compartments , 1999, The Journal of experimental medicine.
[31] S. Porcelli,et al. CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells , 1998, The Journal of experimental medicine.
[32] R. Locksley,et al. Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets. , 1998, Journal of immunology.
[33] S. Balk,et al. Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.
[34] M. Angevine,et al. Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. , 1996, Journal of immunology.
[35] P. Cresswell,et al. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. , 1992, Journal of immunology.
[36] H. Orr,et al. Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Gumperz. Generation of HLA class I transfected target cell lines. , 2000, Methods in molecular biology.
[38] P. Cresswell,et al. Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.